YARW logo

Yarrow Bioscience Inc

YARW
Healthcare|Biotechnology|US
$15.60
+2.00 (+14.71%)
DCF Value
$23.72
Tangible Book / Share
$25.71
Cash / Share
$26.72
Next Earnings Report
Mar 4, 2027
EPS est. -$27.50 · Revenue est. $200.0K
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Sep 11, 2026 (424B5). Possible dilution.

Upcoming Data Readouts (1)

Dec 2027
Est. completion
P2Graves' Disease
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
NCT07682896n=232

Recent Press Releases

Yarrow Bioscience Announces Participation in November Investor Events
Nov 2, 2026 · Business Wire
Yarrow Bioscience Announces Closing of its $172.5 Million Underwritten Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares
Sep 14, 2026 · Business Wire
Yarrow Bioscience Announces Pricing of $150 Million Underwritten Public Offering
Sep 10, 2026 · Business Wire
Yarrow Bioscience Announces Proposed Underwritten Public Offering
Sep 10, 2026 · Business Wire
Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 13, 2026 · Business Wire

SEC Filings (75)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
Sep 17, 2026SC 13GPassive 5%+ stakeDocumentIndex
Sep 14, 20268-KMaterial eventDocumentIndex
Sep 11, 2026424B5Offering prospectusDocumentIndex
Sep 11, 2026424B5Offering prospectusDocumentIndex
Sep 10, 20268-KMaterial eventDocumentIndex
Aug 19, 2026EFFECTDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026POS AMDocumentIndex
Aug 13, 20268-K/AMaterial eventDocumentIndex
Aug 13, 202610-QQuarterly reportDocumentIndex
Aug 13, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 7, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 5, 2026SC 13DActivist / 5%+ stakeDocumentIndex
Aug 4, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 3, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 30, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 30, 20268-KMaterial eventDocumentIndex
Jul 29, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jul 28, 20268-KMaterial eventDocumentIndex
Jul 21, 20268-KMaterial eventDocumentIndex
Jul 20, 20268-KMaterial eventDocumentIndex
Jul 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 14, 2026425DocumentIndex
Jul 14, 20268-KMaterial eventDocumentIndex
Jul 10, 2026425DocumentIndex
Jul 10, 20268-KMaterial eventDocumentIndex
Jun 16, 2026ARSAnnual report to holdersDocumentIndex
Jun 15, 2026EFFECTDocumentIndex
Jun 15, 2026424B3Offering prospectusDocumentIndex
Jun 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 3, 2026S-4/ADocumentIndex
May 21, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 15, 202610-QQuarterly reportDocumentIndex
Apr 28, 2026S-4/ADocumentIndex
Mar 31, 2026S-4DocumentIndex